| pubmed-article:2147709 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2147709 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2147709 | lifeskim:mentions | umls-concept:C0032005 | lld:lifeskim |
| pubmed-article:2147709 | lifeskim:mentions | umls-concept:C0597879 | lld:lifeskim |
| pubmed-article:2147709 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:2147709 | pubmed:dateCreated | 1991-1-22 | lld:pubmed |
| pubmed-article:2147709 | pubmed:abstractText | We evaluated the distribution of lipocortin-1 immunoreactivity in 118 immature or mature human hypophyses using the peroxidase-antiperoxidase (PAP) technique with a polyclonal rabbit antiserum against lipocortin-1. Serial sections were evaluated for five pituitary hormones and S-100 protein immunoreactivity to compare their distributions with that of lipocortin-1. Scattered or moderate numbers of cells exhibited lipocortin-1 immunoreactivity in the pars distalis of 89 subjects ranging in age from 27 weeks' gestation to 83 years. Seven immature and seven aged specimens exhibited no immunostaining, while 15 specimens from older individuals exhibited only rare immunostaining. Immunostaining did not appear to co-localize selectively with any specific pituitary hormone, although the distribution of immunoreactivity did overlap that of some corticotrophs and was seen in elongated processes of S-100-containing folliculostellate cells. Lipocortin-1 was also found in epithelial cells lining colloid cysts of the residual pars intermedia in 115 of 118 pituitaries ranging in age from 23 weeks' gestation to 83 years. In many intermediate lobe cysts, lipocortin-1 exhibited a pattern of immunoreactivity that partially overlapped the distribution of S-100 protein immunostaining, although the pattern was not identical. Pre-absorption of anti-lipocortin-1 antiserum with lipocortin-1-coupled Sepharose-4B immunoreactivity resulted in loss of immunoreactivity in both lobes. No lipocortin-1 immunoreactivity was seen in the neurohypophysis. | lld:pubmed |
| pubmed-article:2147709 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2147709 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2147709 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2147709 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2147709 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2147709 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2147709 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2147709 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2147709 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2147709 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2147709 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2147709 | pubmed:issn | 0022-1554 | lld:pubmed |
| pubmed-article:2147709 | pubmed:author | pubmed-author:PepinskyR BRB | lld:pubmed |
| pubmed-article:2147709 | pubmed:author | pubmed-author:JohnsonM DMD | lld:pubmed |
| pubmed-article:2147709 | pubmed:author | pubmed-author:StahlmanM TMT | lld:pubmed |
| pubmed-article:2147709 | pubmed:author | pubmed-author:GrayM EME | lld:pubmed |
| pubmed-article:2147709 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2147709 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:2147709 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2147709 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2147709 | pubmed:pagination | 1841-5 | lld:pubmed |
| pubmed-article:2147709 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:meshHeading | pubmed-meshheading:2147709-... | lld:pubmed |
| pubmed-article:2147709 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2147709 | pubmed:articleTitle | Lipocortin-1 immunoreactivity in the human pituitary gland. | lld:pubmed |
| pubmed-article:2147709 | pubmed:affiliation | Department of Pathology, Vanderbilt University, School of Medicine, Nashville, Tennessee 37232-2561. | lld:pubmed |
| pubmed-article:2147709 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2147709 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2147709 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
